Lyra Therapeutics LYRA
LYRA
$0.15 +0.12 (+400.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Lyra Therapeutics (LYRA) Interest & Investment Income (2019 - 2025)

Updated

Lyra Therapeutics' Interest & Investment Income came in at $169,000 for Q4 2025, down 61.1% from $435,000 a year earlier and down 34.0% from the prior quarter.

Analysis

Lyra Therapeutics (LYRA) Interest & Investment Income (2019 - 2025) Analysis & Trends

For FY2025, Lyra Therapeutics' Interest & Investment Income was $1.13 million, down 61.6% from FY2024.

  • Interest & Investment Income carries a five-year compound annual growth rate of 69.1% (FY2020 to FY2025).
  • Going back by year, Interest & Investment Income was $2.95 million in FY2024 (-34.4%), $4.5 million in FY2023 (+332.2%), $1.04 million in FY2022 (+920.6%) and $102,000 in FY2021 (+24.4%).
  • The Q4 2025 figure represents the lowest quarterly Interest & Investment Income since Q3 2022.
  • Year-over-year, Interest & Investment Income has declined for seven consecutive quarters, with an average decline of 45.5% over the last eight quarters.
  • The fastest year-over-year change in Interest & Investment Income over five years came in Q2 2021 (growth of 420.0%), and the weakest in Q1 2025 (a decline of 72.6%).
  • Business Quant data shows LYRA's Interest & Investment Income at $256,000 (Q3 2025), $410,000 (Q2 2025) and $298,000 (Q1 2025) in the three quarters before Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Lyra Therapeutics 266,232.31 266,232.31 - 169,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 169,000.00
Sep 30, 2025 256,000.00
Jun 30, 2025 410,000.00
Mar 31, 2025 298,000.00
Dec 31, 2024 435,000.00
Sep 30, 2024 576,000.00
Jun 30, 2024 855,000.00
Mar 31, 2024 1.09 Mn
Dec 31, 2023 1.34 Mn
Sep 30, 2023 1.19 Mn
Jun 30, 2023 897,000.00
Mar 31, 2023 1.07 Mn
Dec 31, 2022 933,000.00
Sep 30, 2022 60,000.00
Jun 30, 2022 34,000.00
Mar 31, 2022 14,000.00
Dec 31, 2021 21,000.00
Sep 30, 2021 26,000.00
Jun 30, 2021 26,000.00
Mar 31, 2021 29,000.00
API Access

Lyra Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=LYRA&period=max&api_key=YOUR_API_KEY